Evaluation of the Functional Suitability of Carboxylate Chlorin e6 Derivatives for Use in Radionuclide Diagnostics; Pharmaceutics; Vol. 18, iss. 1

Bibliographische Detailangaben
Parent link:Pharmaceutics.— .— Basel: MDPI AG
Vol. 18, iss. 1.— 2026.— Article number 23, 23 p.
Weitere Verfasser: Larkina M. S. Mariya Sergeevna, Demina A. Anastasia, Suvorov N. Nikita, Ostroverkhov P. Petr, Plotnikov E. V. Evgeny Vladimirovich, Varvashenya R. N. Ruslan Nikolaevich, Bodenko V. V. Vitalina Vasiljevna, Yanovich G. Gleb, Prach A. A. Anastasiya Aleksandrovna, Pogorilyy V. Viktor, Tikhonov S. Sergey, Popov A. Alexander, Usachev M. Maxim, Volel B. Beatrice, Vasil’ev Yu. Yuriy, Belousov M. Mikhail, Grin M. Mikhail
Zusammenfassung:Radionuclide-based molecular imaging modalities are active and developing areas of functional and molecular diagnosis. Among the radionuclides used for SPECT imaging in oncology, 99mTc is a leading candidate for radiolabeling. At present, a sufficient number of complexons for 99mTc have been described; however, the development of effective delivery systems for this isotope to the area of interest is a complex research task. The use of tumor-targeting molecules as carriers for radioactive tracers is an effective strategy that has enabled the development of many novel radiopharmaceuticals for cancer imaging. Background: To date, a number of studies have shown tumorotropicity of tetrapyrrole compounds to tumor tissues, in particular derivatives of natural chlorophyll A. Methods: Purification was performed using solid-phase extraction. Assessment of radiochemical yield and purity was performed via radio-ITLC. The in vitro tumor cell accumulation was assessed using SKOV-3 and A-431 cell lines. Dose-dependent biodistribution was evaluated in Nu/J mice bearing epidermoid carcinoma (A-431) xenografts. Results: In this work, we obtained complexes with 99mTc based on water-soluble carboxylate chlorin e6 derivatives in order to evaluate their potential for use as SPECT radiopharmaceuticals. We performed radiolabelling optimization of a series of the novel chlorins and primary preclinical studies, including an assessment of the effect of their lipophilicity and charge on tumor uptake. Conclusions: Modification of the periphery of the chlorin macrocycle with chelating groups allows for complexing a wide range of metals, including 99mTc, which can be used for targeted delivery of the radionuclide to the area of interest
Текстовый файл
Sprache:Englisch
Veröffentlicht: 2026
Schlagworte:
Online-Zugang:https://doi.org/10.3390/pharmaceutics18010023
Format: Elektronisch Buchkapitel
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=685391

MARC

LEADER 00000naa0a2200000 4500
001 685391
005 20260311103131.0
090 |a 685391 
100 |a 20260311d2026 k||y0rusy50 ba 
101 1 |a eng 
102 |a CH 
135 |a drcn ---uucaa 
181 0 |a i   |b  e  
182 0 |a b 
183 0 |a cr  |2 RDAcarrier 
200 1 |a Evaluation of the Functional Suitability of Carboxylate Chlorin e6 Derivatives for Use in Radionuclide Diagnostics  |f M. Larkina, A. Demina, N. Suvorov [et al.] 
203 |a Текст  |b визуальный  |c электронный 
283 |a online_resource  |2 RDAcarrier 
320 |a References: 92 tit 
330 |a Radionuclide-based molecular imaging modalities are active and developing areas of functional and molecular diagnosis. Among the radionuclides used for SPECT imaging in oncology, 99mTc is a leading candidate for radiolabeling. At present, a sufficient number of complexons for 99mTc have been described; however, the development of effective delivery systems for this isotope to the area of interest is a complex research task. The use of tumor-targeting molecules as carriers for radioactive tracers is an effective strategy that has enabled the development of many novel radiopharmaceuticals for cancer imaging. Background: To date, a number of studies have shown tumorotropicity of tetrapyrrole compounds to tumor tissues, in particular derivatives of natural chlorophyll A. Methods: Purification was performed using solid-phase extraction. Assessment of radiochemical yield and purity was performed via radio-ITLC. The in vitro tumor cell accumulation was assessed using SKOV-3 and A-431 cell lines. Dose-dependent biodistribution was evaluated in Nu/J mice bearing epidermoid carcinoma (A-431) xenografts. Results: In this work, we obtained complexes with 99mTc based on water-soluble carboxylate chlorin e6 derivatives in order to evaluate their potential for use as SPECT radiopharmaceuticals. We performed radiolabelling optimization of a series of the novel chlorins and primary preclinical studies, including an assessment of the effect of their lipophilicity and charge on tumor uptake. Conclusions: Modification of the periphery of the chlorin macrocycle with chelating groups allows for complexing a wide range of metals, including 99mTc, which can be used for targeted delivery of the radionuclide to the area of interest 
336 |a Текстовый файл 
461 1 |t Pharmaceutics  |c Basel  |n MDPI AG 
463 1 |t Vol. 18, iss. 1  |v Article number 23, 23 p.  |d 2026 
610 1 |a technetium-99m 
610 1 |a chlorin 
610 1 |a DTPA 
610 1 |a radiopharmaceuticals 
610 1 |a iminodiacetic acid; cancer 
610 1 |a труды учёных ТПУ 
610 1 |a электронный ресурс 
701 1 |a Larkina  |b M. S.  |g Mariya Sergeevna  |f 1984-  |c pharmacist  |c Professor; Senior Researcher of the Tomsk Polytechnic University, Doctor of Pharmaceutical Sciences  |9 22417 
701 1 |a Demina  |b A.  |g Anastasia 
701 1 |a Suvorov  |b N.  |g Nikita 
701 1 |a Ostroverkhov  |b P.  |g Petr 
701 1 |a Plotnikov  |b E. V.  |c chemist  |c Associate Professor of Tomsk Polytechnic University, Candidate of Chemical Sciences  |f 1983-  |g Evgeny Vladimirovich  |9 16417 
701 1 |a Varvashenya  |b R. N.  |c pharmacist  |c engineer at Tomsk Polytechnic University  |f 1997-  |g Ruslan Nikolaevich  |9 88559 
701 1 |a Bodenko  |b V. V.  |c pharmacist  |c engineer at Tomsk Polytechnic University  |f 1997-  |g Vitalina Vasiljevna  |9 88553 
701 1 |a Yanovich  |b G.  |c Pharmacist  |c engineer of Tomsk Polytechnic University  |f 1999-  |g Gleb  |9 89205 
701 1 |a Prach  |b A. A.  |g Anastasiya Aleksandrovna  |f 1999-  |c chemist  |c engineer of Tomsk Polytechnic University  |9 88930 
701 1 |a Pogorilyy  |b V.  |g Viktor 
701 1 |a Tikhonov  |b S.  |g Sergey 
701 1 |a Popov  |b A.  |g Alexander 
701 1 |a Usachev  |b M.  |g Maxim 
701 1 |a Volel  |b B.  |g Beatrice 
701 1 |a Vasil’ev  |b Yu.  |g Yuriy 
701 1 |a Belousov  |b M.  |g Mikhail 
701 1 |a Grin  |b M.  |g Mikhail 
801 0 |a RU  |b 63413507  |c 20260311 
850 |a 63413507 
856 4 0 |u https://doi.org/10.3390/pharmaceutics18010023  |z https://doi.org/10.3390/pharmaceutics18010023 
942 |c CF